VYOME HOLDINGS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VYOME HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $5.29M.
- VYOME HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $5.90M.
- VYOME HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $9.24M.
- VYOME HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $0.00.
- VYOME HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2023 was $10.14M, a 1486.85% increase from fiscal 2022.
- VYOME HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2022 was $639.00K.
- VYOME HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2018 was $10.42M.
- VYOME HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2016 was $67.23M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $5.29M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $5.90M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $10.14M 10-K · filed 2025-04-04 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2023-06-30 | $894.00K 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $639.00K 10-K · filed 2024-04-01 | |
| 2019-09-30 | $14.72M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $8.07M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $581.00K 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $10.42M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $9.82M 10-Q · filed 2019-11-08 | |
| 2016-12-31 | $67.23M 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |